Accession Number: | 0001209191-20-054908 |
Date: | 2020-10-13 |
Issuer: | HERON THERAPEUTICS, INC. /DE/ (HRTX) |
Original Submission Date: |
POYHONEN JOHN
4242 CAMPUS POINT COURT
SUITE 200
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 15.72 | 2020-10-13 | deemed execution date | A | 170,000 (a) | 2030-10-13 | common stock 170,000 | $15.72 | 170,000 | direct | ||
RESTRICTED STOCK UNITS | 0.0 | 2020-10-13 | deemed execution date | A | 20,000 (a) | common stock 20,000 | $0.00 | 20,000 | direct |
ID | footnote |
---|---|
f1 | the stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant. |
f2 | the restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant. |